Analysts Expect Healthequity Inc (NASDAQ:HQY) to Post $0.34 EPS

Equities research analysts expect Healthequity Inc (NASDAQ:HQY) to report earnings of $0.34 per share for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Healthequity’s earnings. Healthequity also posted earnings per share of $0.34 during the same quarter last year. The business is expected to announce its next quarterly earnings results on Tuesday, September 3rd.

According to Zacks, analysts expect that Healthequity will report full-year earnings of $1.33 per share for the current financial year, with EPS estimates ranging from $1.32 to $1.34. For the next year, analysts expect that the business will report earnings of $1.55 per share, with EPS estimates ranging from $1.44 to $1.63. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for Healthequity.

Healthequity (NASDAQ:HQY) last issued its earnings results on Tuesday, June 4th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.11. The business had revenue of $87.05 million for the quarter, compared to analyst estimates of $83.98 million. Healthequity had a return on equity of 14.17% and a net margin of 30.60%.

A number of analysts have recently weighed in on HQY shares. BidaskClub upgraded Healthequity from a “hold” rating to a “buy” rating in a research report on Friday, July 19th. JPMorgan Chase & Co. set a $80.00 price target on Healthequity and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Bank of America raised Healthequity from a “neutral” rating to a “buy” rating and increased their price target for the company from $75.00 to $90.00 in a research note on Friday, July 19th. ValuEngine raised Healthequity from a “hold” rating to a “buy” rating in a research note on Wednesday, July 17th. Finally, Zacks Investment Research raised Healthequity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 21st. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $87.92.

NASDAQ HQY traded up $1.01 on Wednesday, hitting $82.92. 577,833 shares of the stock traded hands, compared to its average volume of 1,473,131. The company has a 50-day moving average price of $70.73. Healthequity has a twelve month low of $50.29 and a twelve month high of $101.58. The stock has a market capitalization of $5.20 billion, a P/E ratio of 87.28, a P/E/G ratio of 4.01 and a beta of 1.46. The company has a debt-to-equity ratio of 0.07, a current ratio of 15.60 and a quick ratio of 15.59.

In other Healthequity news, EVP Delano Ladd sold 6,875 shares of the firm’s stock in a transaction dated Monday, July 22nd. The shares were sold at an average price of $80.00, for a total transaction of $550,000.00. Following the completion of the transaction, the executive vice president now owns 17,833 shares in the company, valued at $1,426,640. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $68.17, for a total transaction of $272,680.00. Following the transaction, the vice president now owns 64,100 shares of the company’s stock, valued at approximately $4,369,697. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 37,899 shares of company stock valued at $2,780,851. Corporate insiders own 3.70% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Deutsche Bank AG lifted its holdings in shares of Healthequity by 29.7% during the 4th quarter. Deutsche Bank AG now owns 383,388 shares of the company’s stock worth $22,867,000 after acquiring an additional 87,736 shares during the period. Neuburgh Advisers LLC raised its holdings in shares of Healthequity by 5.6% in the first quarter. Neuburgh Advisers LLC now owns 31,600 shares of the company’s stock valued at $2,338,000 after acquiring an additional 1,664 shares in the last quarter. Bfsg LLC bought a new stake in shares of Healthequity in the first quarter valued at about $460,000. Sawtooth Solutions LLC bought a new stake in shares of Healthequity in the first quarter valued at about $325,000. Finally, Keeler Thomas Management LLC raised its holdings in shares of Healthequity by 9.9% in the first quarter. Keeler Thomas Management LLC now owns 16,730 shares of the company’s stock valued at $1,237,000 after acquiring an additional 1,505 shares in the last quarter. Hedge funds and other institutional investors own 96.50% of the company’s stock.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: What are different types of coverage ratios?

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.